Works matching IS 22351795 AND DT 2024 AND VI 13 AND IP 3
Results: 9
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 1, doi. 10.1159/000539902
- Publication type:
- Article
Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 227, doi. 10.1159/000538558
- By:
- Publication type:
- Article
A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial).
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 322, doi. 10.1159/000535514
- By:
- Publication type:
- Article
Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 306, doi. 10.1159/000534513
- By:
- Publication type:
- Article
Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 246, doi. 10.1159/000534303
- By:
- Publication type:
- Article
Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 235, doi. 10.1159/000533991
- By:
- Publication type:
- Article
Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 285, doi. 10.1159/000533818
- By:
- Publication type:
- Article
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 256, doi. 10.1159/000533650
- By:
- Publication type:
- Article
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 273, doi. 10.1159/000533425
- By:
- Publication type:
- Article